Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms, Medaffcon Partner for Data Harmonization

NEW YORK (GenomeWeb) – BC Platforms is joining with with medical evidence provider Medaffcon in an effort to harmonize genomic and clinical data gathered from multiple sources, the companies said today. Financial terms of the partnership were not disclosed.

Medaffcon specializes in generating medical evidence from biobank-based research. Under the partnership with Switzerland-based BC Platforms, Medaffcon will be leveraging the global biobank analytics platform, the companies said.

"The collaboration will expand our capabilities of accessing and combining different Finnish and international data sources to advance research," Jaana Ahlamaa, Medaffcon's medical and market access director, said in a statement.

"Our goal is to combine our global platform to leverage Medaffcon's extensive expertise in key markets in order to utilize real-world evidence faster and more effectively," added BC Platforms CEO Tero Silvola.

Espoo, Finland-based Medaffcon is a wholly owned subsidiary of German pharmaceutical distributor the Phoenix Group.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.